Log in to your IBTimes Account

close
ID
Password
  • Set your IBTimes.com Edition

Chindex gets contracts worth $17 million



By AP
11 July 2008 @ 04:43 pm ET

BETHESDA, Md. - Chindex International Inc., which makes tumor therapy and in-vitro diagnostic equipment, said Friday that it signed contracts worth 10.8 million euros ($17 million) to supply laboratory and hospital products to Centers for Disease Control in China's Gansu and Inner Mongolia provinces.

Related Topic

Get stories by e-mail on this topic.

E-mail:
Quotes
CHDX 5.99 -0.33

Shipments under the two contracts are expected to begin by the end of the year.

Chindex is continuing to bid for several other government-sponsored loan projects, which the company sees as its primary method of maintaining profitability.

Shares fell 8 cents to close at $15.87.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

    Click!
  • Rate this article:

Comments

Post Your Comment

*Name


advertisement
More Industries
China's ambitious plan to increase wind power capacity could attract up to $150 billion in investment, but Beijing will have to get serious about revampi...
Top oil and gas firm PetroChina raised daily output at its largest Sulige gasfield, in northern China's Ordos Basin, to 25.6 million cubic metres, up 67 ...
Volkswagen chief executive Martin Winterkorn said Europe's largest auto maker sold 6 percent more cars and transporters in June than in the same month a ...

Advertisement
Press Release Distribution - IBwire

Effective and Affordable Press Release Distribution Service

Forex trading is too complicated?

Can predict currency pairs movements? Binary option trading is what you need. Click here.

70% Profit in Less Than an Hour

Take profit from the markets roller coaster. No downloads, no commissions, no spreads.

advertisement
 
IBTimes.com Web
Partners
International Business Times© 2009 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives